DK145504C - Fremgangsmaade til fremstilling af det antibiotiske stof 890a2og/eller det antibiotiske stof 890a5 og farmaceutisk acceptable salte deraf - Google Patents
Fremgangsmaade til fremstilling af det antibiotiske stof 890a2og/eller det antibiotiske stof 890a5 og farmaceutisk acceptable salte derafInfo
- Publication number
- DK145504C DK145504C DK163977A DK163977A DK145504C DK 145504 C DK145504 C DK 145504C DK 163977 A DK163977 A DK 163977A DK 163977 A DK163977 A DK 163977A DK 145504 C DK145504 C DK 145504C
- Authority
- DK
- Denmark
- Prior art keywords
- antibiotic substance
- 890a2og
- procedure
- preparation
- acceptable salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
- C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68083176A | 1976-04-28 | 1976-04-28 | |
US68083176 | 1976-04-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK163977A DK163977A (da) | 1977-10-29 |
DK145504B DK145504B (da) | 1982-11-29 |
DK145504C true DK145504C (da) | 1983-04-25 |
Family
ID=24732704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK163977A DK145504C (da) | 1976-04-28 | 1977-04-13 | Fremgangsmaade til fremstilling af det antibiotiske stof 890a2og/eller det antibiotiske stof 890a5 og farmaceutisk acceptable salte deraf |
Country Status (11)
Country | Link |
---|---|
US (2) | US4168202A (fr) |
JP (1) | JPS52131596A (fr) |
CH (1) | CH634599A5 (fr) |
DE (1) | DE2718782A1 (fr) |
DK (1) | DK145504C (fr) |
ES (1) | ES458070A1 (fr) |
FR (1) | FR2349586A1 (fr) |
GB (1) | GB1547949A (fr) |
NL (1) | NL7704040A (fr) |
PT (1) | PT66476B (fr) |
SE (1) | SE435935B (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2808563A1 (de) * | 1977-03-05 | 1978-09-07 | Beecham Group Ltd | Derivate der 3-thio-6-(1-hydroxyaethyl)-7-oxo-1-aza-bicyclo eckige klammer auf 3.2.0 eckige klammer zu hept-2-en- 2-carbonsaeure, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
GR62185B (en) * | 1977-03-31 | 1979-03-02 | Panlabs Inc | Preparation process of an antibiotic ps-5 and its derivatives with inhibitory activity of b-lactamase |
US4162323A (en) * | 1977-04-18 | 1979-07-24 | Merck & Co., Inc. | Antibiotic N-acetyl-dehydro-thienamycin |
DE2963717D1 (en) * | 1978-05-06 | 1982-11-04 | Beecham Group Plc | Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them |
US4446146A (en) * | 1978-07-26 | 1984-05-01 | Beecham Group Limited | β-Lactam containing compounds, their preparation and use |
DE2966446D1 (en) * | 1978-09-09 | 1984-01-05 | Beecham Group Plc | Beta-lactam compounds, their preparation and use |
DE3164021D1 (en) | 1980-01-25 | 1984-07-19 | Beecham Group Plc | Beta-lactam containing compounds, their preparation and use |
US4409147A (en) * | 1980-03-10 | 1983-10-11 | Takeda Chemical Industries, Ltd. | Carbapenem compounds and their production |
JPS57109786A (en) * | 1980-12-26 | 1982-07-08 | Takeda Chem Ind Ltd | Antibiotic c-19393e5 and its preparation |
DE3827362A1 (de) * | 1988-08-12 | 1990-02-15 | Basf Ag | Pulvrige, hydrophile theophyllinformulierung und verfahren zur ihrer herstellung |
US5691191A (en) * | 1996-03-15 | 1997-11-25 | Agraquest, Inc. | Medium for the cultivation of lagenidium giganteum |
EP0954562A4 (fr) * | 1997-06-17 | 2000-05-10 | Agraquest Inc | Milieu nutritif permettant d'accroitre la production cellulaire lors d'une fermentation |
WO2003017780A1 (fr) * | 2001-08-27 | 2003-03-06 | Advanced Bionutrition Corporation | Apport de produits de lutte contre les maladies en aquaculture et agriculture au moyen d'aliments nutritionnels contenant des proteines bioactives produites par des virus |
US7550647B2 (en) * | 2001-09-14 | 2009-06-23 | Advanced Bionutrition | Transfected shrimp as production systems for therapeutic proteins |
CA2460558A1 (fr) * | 2001-09-14 | 2003-03-27 | Advanced Bionutrition Corporation | Crustaces utilises comme systemes de production de proteines therapeutiques |
US20060035310A1 (en) * | 2004-08-13 | 2006-02-16 | Millipore Corporation | Media for recovery of microorganism in the presence of antibiotics |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1489235A (en) * | 1974-03-28 | 1977-10-19 | Beecham Group Ltd | Antibiotics |
US3950357A (en) * | 1974-11-25 | 1976-04-13 | Merck & Co., Inc. | Antibiotics |
DK143712C (da) * | 1975-11-21 | 1982-03-22 | Merck & Co Inc | Fremgangsmaade til fremstilling af de antibiotiske stoffer 890a1 og 890a3 |
-
1977
- 1977-04-13 NL NL7704040A patent/NL7704040A/xx not_active Application Discontinuation
- 1977-04-13 DK DK163977A patent/DK145504C/da not_active IP Right Cessation
- 1977-04-14 SE SE7704301A patent/SE435935B/xx not_active IP Right Cessation
- 1977-04-20 FR FR7711891A patent/FR2349586A1/fr active Granted
- 1977-04-21 ES ES458070A patent/ES458070A1/es not_active Expired
- 1977-04-26 PT PT66476A patent/PT66476B/pt unknown
- 1977-04-26 GB GB17351/77A patent/GB1547949A/en not_active Expired
- 1977-04-27 CH CH523777A patent/CH634599A5/de not_active IP Right Cessation
- 1977-04-27 DE DE19772718782 patent/DE2718782A1/de active Granted
- 1977-04-28 JP JP4859477A patent/JPS52131596A/ja active Granted
- 1977-07-08 US US05/813,908 patent/US4168202A/en not_active Expired - Lifetime
- 1977-08-05 US US05/823,258 patent/US4141986A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
SE7704301L (sv) | 1977-10-29 |
JPS631315B2 (fr) | 1988-01-12 |
FR2349586B1 (fr) | 1979-03-23 |
FR2349586A1 (fr) | 1977-11-25 |
GB1547949A (en) | 1979-07-04 |
US4141986A (en) | 1979-02-27 |
JPS52131596A (en) | 1977-11-04 |
DE2718782A1 (de) | 1977-11-17 |
DE2718782C2 (fr) | 1989-11-30 |
US4168202A (en) | 1979-09-18 |
PT66476A (en) | 1977-05-01 |
ES458070A1 (es) | 1978-08-16 |
SE435935B (sv) | 1984-10-29 |
DK145504B (da) | 1982-11-29 |
CH634599A5 (de) | 1983-02-15 |
PT66476B (en) | 1979-03-12 |
DK163977A (da) | 1977-10-29 |
NL7704040A (nl) | 1977-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK149449C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf | |
DK145504C (da) | Fremgangsmaade til fremstilling af det antibiotiske stof 890a2og/eller det antibiotiske stof 890a5 og farmaceutisk acceptable salte deraf | |
DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
DK150278A (da) | Fremgangsmaade til fremstilling af et antibiotisk stof kaldet n-acetyl-dehydrothienamycin eller farmaceutisk acceptable salte deraf | |
DK503080A (da) | Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf | |
DK5976A (da) | Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf | |
DK236377A (da) | Fremgangsmade til fremstilling af substituerede pyridiner el6er farmaceutisk acceptable salte deraf | |
DK496977A (da) | Fremgangsmaade til fremstilling af 0-alkylerede hydroxylaminer og syreadditionssalte deraf | |
DK445078A (da) | Fremgangsmaade til fremstilling af 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyklisk arylimidazoler og derivater deraf | |
DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
DK11480A (da) | Fremgangsmaade til fremstilling af anthracyclinderivater og syreadditionssalte deraf | |
DK155670C (da) | Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf | |
DK72476A (da) | Fremgangsmade til fremstilling af tetralon- og indanonderivater | |
DK232777A (da) | Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
DK236477A (da) | Fremgangsmade til fremstilling af 3-cyan2-(3-alkylamino-2-aciloxy-propoxy)-pyridiner eller farmaceutisk acceptable aalte :eraf | |
DK165677A (da) | Fremgangsmade til fremstilling af thiourinstofderivater | |
DK58677A (da) | Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf | |
DK338376A (da) | Fremgangsmade til fremstilling af aminobenzocycloheptenderivater eller additionssalte deraf | |
DK232677A (da) | Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf | |
DK232877A (da) | Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf | |
DK267078A (da) | Fremgangsmaade til fremstilling af n1-glucofuranosid-6-yl-n3-n3-nitrosourinstoffer og derivater deraf | |
DK147623C (da) | Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf | |
DK127676A (da) | Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf | |
DK160422C (da) | Fremgangsmaade til fremstilling af svovlholdige isoquinolinderivater eller salte eller cycliske amider deraf | |
DK150521C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed | ||
PBP | Patent lapsed |